EWA
FLGT icon

EverSource Wealth Advisors’s Fulgent Genetics FLGT Stock Holding History

EverSource Wealth Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.65K Buy
129
+108
+514% +$1.83K ﹤0.01% 3604
2026
Q1 		$334 Sell
21
-170
-89% -$3.69K ﹤0.01% 4126
2025
Q4 		$5.02K Sell
191
-24
-11% -$623 ﹤0.01% 3119
2025
Q3 		$4.86K Sell
215
-5
-2% -$103 ﹤0.01% 3159
2025
Q2 		$4.37K Buy
220
+187
+567% +$3.65K ﹤0.01% 3216
2025
Q1 		$558 Sell
33
-20
-38% -$341 ﹤0.01% 3418
2024
Q4 		$979 Sell
53
-209
-80% -$4.08K ﹤0.01% 2968
2024
Q3 		$5.69K Buy
262
+32
+14% +$715 ﹤0.01% 2177
2024
Q2 		$5.5K Buy
230
+162
+238% +$3.38K ﹤0.01% 2190
2024
Q1 		$1.38K Sell
68
-7
-9% -$174 ﹤0.01% 2483
2023
Q4 		$2.17K Buy
75
+47
+168% +$1.26K ﹤0.01% 2141
2023
Q3 		$749 Hold
28
– – ﹤0.01% 2313
2023
Q2 		$1.04K Hold
28
– – ﹤0.01% 2209
2023
Q1 		$874 Sell
28
-75
-73% -$2.41K ﹤0.01% 2142
2022
Q4 		$3.07K Sell
103
-49
-32% -$1.75K ﹤0.01% 1781
2022
Q3 		$6K Hold
152
– – ﹤0.01% 1287
2022
Q2 		$8K Hold
152
– – ﹤0.01% 1104
2022
Q1 		$9K Hold
152
– – ﹤0.01% 1009
2021
Q4 		$15K Buy
+152
New +$13.4K ﹤0.01% 798

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EverSource Wealth Advisors's FLGT Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Fulgent Genetics (FLGT) stake by 514% in Q2 2026, buying an estimated $1.83K and bringing the position to 129 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #3604.

EverSource Wealth Advisors first reported a position in FLGT in Q4 2021 and has held it in 19 quarters since. The position peaked at $15K in Q4 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • EverSource Wealth Advisors held 129 shares of Fulgent Genetics worth $2.65K as of Q2 2026.
  • EverSource Wealth Advisors bought 108 Fulgent Genetics shares in Q2 2026, an estimated $1.83K.
  • Fulgent Genetics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3604 holding.
  • EverSource Wealth Advisors first reported a position in Fulgent Genetics in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's Fulgent Genetics position peaked at $15K in Q4 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.